title: Critical renal adverse event induced by nivolumab therapy in a stage IV melanoma patient.
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Aya
authors.initials: A
authors.lastname: Tanaka
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Kuniko
authors.initials: K
authors.lastname: Ikinaga
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Eiji
authors.initials: E
authors.lastname: Kiyohara
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tanemura
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Mari
authors.initials: M
authors.lastname: Wataya-Kaneda
authors.affiliation: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Ryuta
authors.initials: R
authors.lastname: Fujimura
authors.affiliation: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Mizui
authors.affiliation: Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Isaka
authors.affiliation: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000652:urine; D000284:Administration, Oral; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007684:Kidney Tubules / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology; D009395:Nephritis, Interstitial / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000652:urine; D000077594:Nivolumab / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome; D001613:beta 2-Microglobulin / Q000652:urine
chemical_list: D000970:Antineoplastic Agents; C000630045:B2M protein, human; D001613:beta 2-Microglobulin; D000077594:Nivolumab; D011239:Prednisolone; D003404:Creatinine